| Date: 2025/07/23 | File Size: 96.91 MB |
| Duration: 00:00:52 | Frame Size: 1920 x 1080 |
AstraZeneca announced a planned investment of $50 billion in the United States by 2030, aimed at expanding its manufacturing and research and development activities. The investment supports the company's goal of reaching $80 billion in revenue by 2030, with half of that total expected to be generated in the U.S.